Home Emergex Vaccines

Emergex Vaccines

In operation
Series A
Vaccine Developer
Basic
Enterprise Profile

Basic Information

Emergex Vaccines Holding Limited, a UK-based biotechnology company headquartered in Oxford, is pioneering a new approach to vaccine development. It is dedicated to addressing some of the most pressing health threats worldwide, including viral diseases such as dengue fever, Zika virus, Ebola virus, and pandemic influenza, as well as severe intracellular bacterial infections, with a growing pipeline of candidate vaccines.
Emergex Vaccines Holding Ltd
England,United Kingdom
less than 15 people
January 01, 2016
info@emergexvaccines.com

Enterprise Profile

Industrial Sector
Vaccine Formulation Production
Technology
Microbial/Viral Technology Antibacterial/Antiviral Technology
Concept
Vaccination
Application Scenarios
Traditional Vaccines (Biological Products for Prevention)